Company news

Sophia Genetics SA news in 2025

Sophia Genetics SA's news releases, calls and decks from 2025, newest first.

View company

Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria

December 4, 2025

Seguros SURA Colombia Adopts MSK-ACCESS® powered by SOPHiA DDM™

November 19, 2025

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

November 11, 2025

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

November 11, 2025

Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025

November 10, 2025

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

November 4, 2025

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

October 21, 2025

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

October 16, 2025

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

October 15, 2025

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

September 22, 2025

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

September 22, 2025

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

September 5, 2025

SOPHiA GENETICS Reports Second Quarter 2025 Results

August 5, 2025

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

August 5, 2025

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

July 22, 2025

SOPHiA GENETICS Reports First Quarter 2025 Results

May 6, 2025

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

April 28, 2025

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

April 22, 2025

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

April 7, 2025

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

March 18, 2025

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

March 4, 2025

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

February 24, 2025

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

February 18, 2025

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

January 27, 2025

Calls in 2025

Decks in 2025